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Abstract 
Intranodal palisaded myofibroblastoma is a rare and benign tumour that usually presents in the inguinal 
region. We report a case of a 68 year-old woman who presented with a right paratracheal mass and a 
right upper lobe non-small cell lung carcinoma initially staged T1b N2 M0. Following, mediastinal 
staging, the right paratracheal mass was found to be an intranodal palisaded myofibroblastoma which 
had caused erroneous upstaging of the lung carcinoma to N2 disease. This had the potential of leading 
to suboptimal treatment of the primary lung carcinoma if formal mediastinal staging had not been 
performed. To the best of our knowledge, this is the first ever report in the English literature of an 
intranodal palisaded myofibroblastoma occurring concurrently with a lung cancer. This case highlights 
the importance of mediastinal staging in lung cancer and Mediastinoscopy remains the gold standard.  
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Introduction 
Intranodal palisaded myofibroblastoma (IPM) is a rare, benign, mesenchymal tumour of modified 
smooth muscle cells or myofibroblasts. It normally presents in middle aged men as a painless, slow 
growing inguinal mass1 but IPM has, on extremely rare occasions, been reported in other sites including 
the submandibular region and retroperitoneum2-4. We report a case of IPM in the paratracheal zone of 
a 68-year-old female, which presented concurrently with a non-small cell carcinoma, causing erroneous 
upstaging to N2 disease. To our knowledge, this is the first report of IPM in the mediastinum presenting 
concurrently with a lung carcinoma. 
  
Case Report 
A 68-year-old woman, who was an ex-smoker with no other significant co-morbidities, presented with 
a 2-month history of chronic cough. Chest plain film radiography was abnormal, thus a CT scan was 
arranged which showed a right upper lobe nodule and a right paratracheal mass. Subsequent PET-CT 
revealed a right 3.6cm x 5.9cm paratracheal mass which was FDG avid (SUV 6.2g/ml) (figure 1A) with 
an area of crescentic low grade FDG uptake (SUV 2.7g/ml) in the right upper lobe (figure 1B). The 
patient was discussed in the lung cancer multidisciplinary team meeting with the provisional staging of 
T1b N2 M0 (Stage IIIa) non small cell lung carcinoma. An endobronchial ultrasound guided fine needle 
aspiration was then performed to confirm N2 status but no definite malignant cells were seen; the fine 
needle aspirate only contained inflammatory cells and fragments of debris, the area of clinical interest 
probably had not been sampled. Therefore, a Mediastinoscopy was arranged and the R4 lymph node 
sampled. Histology showed tissue with the appearances of a benign soft tissue tumour showing 
myofibroblastic differentiation consistent with intranodal palisaded myofibroblastoma. The pathology 
opinion at the time was that this was unlikely to be related to the radiological mass within the right 
upper lobe and that the patient should be referred for a formal lung resection. 
  
The operation was performed using a VATS posterior approach as previously described5.  The right 
upper lobe lesion was identified and removed as a wedge resection and sent for frozen section. 
Meanwhile, the mediastinal pleura overlying the paratracheal mass (figure 2) was opened in a triangular 
fashion above the azygous vein and the mass dissected out en-bloc and removed from the chest in an 
endobag. The frozen section result confirmed a non-small-cell lung carcinoma and therefore we 
proceeded to a right upper lobectomy. The hilar anatomy was unusual: the upper lobe bronchus had a 
very low bifurcation; the lower lobe apical segment vein drained into the posterior segment vein of the 
upper lobe rather than the inferior pulmonary vein and the all arterial branches to the upper lobe arose 
from a common anterior trunk. The specimen was removed and lymph nodes dissected from the 
subcarinal and paraoesophageal areas.  An extrapleural catheter and chest drain were placed, the lung 
inflated and wounds closed.  
 
Histopathology 
The final pathological diagnosis and staging of the right upper node lesion was that of moderately 
differentiated adenocarcinoma pT1b N0. 
  
Sections from the right paratracheal mass (figure 3) showed a circumscribed encapsulated spindle cell 
neoplasm. This was composed of bland spindle cells showing a well developed palisaded morphological 
pattern with amianthoid fibres.  There was no significant cytological atypia and no mitotic figures were 
identified.  Extravasation of red blood cells was present within the neoplasm and a cuff of residual 
lymphoid tissue surrounded the tumour.  Immunohistochemistry confirmed the spindle cells were of 
myofibroblastic origin (smooth muscle actin positive, calponin positive, S100 negative). 
 
Comment 
This is a rare case where a mediastinal intranodal palisaded myofibroblastoma, interpreted 
radiologically as metastatic carcinoma, had caused erroneous upstaging (stage IIIA rather stage IA) in 
a patient with NSCLC. The patient was clinically thought to have bulky single zone N2 disease.  This 
case highlights the importance of accurate mediastinal staging of all lung cancer patients as 
recommended by the Euopean Society of Thoracic Surgeons guidelines and mediastinoscopy remains 
the gold standard technique6; especially in this case as an endobronchial ultrasound guided fine needle 
aspirate had essentially failed to biopsy the target. To the best of our knowledge this is the first described 
report of IPM presenting concurrently with NSCLC and of IPM in an unusual location – the paratracheal 
area.    
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Figure Legend 
 
 
1A.  PET-CT scan showing right paratracheal mass PET avid with SUV 6.2g/ml. 
 
1B.  PET-CT scan showing right upper lobe mass PET avid with SUV 2.7g/ml. 
 
2.  Intra-operative image showing right sided paratracheal mass. 
 
3. Intranodal Palisaded Myofibroblastoma- histology section stained with Haematoxylin 
and Eosin at x20 magnification. 
